ArticleHaematologica2011

The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia.

Philip Saunders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.